10,5-(Iminomethano)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene and derivatives. Potent PCP receptor ligands

IDDC (3, 10,5-(iminomethano)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene++ +) and a series of substituted derivatives were synthesized and evaluated in vitro for their ability to displace tritiated MK-801 ([3H]-2) from its specific binding site in guinea pig brain homogenate. Substitution at the 3-pos...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 36; no. 14; pp. 1938 - 1946
Main Authors Gee, Kyle R, Barmettler, Peter, Rhodes, Michael R, McBurney, Robert N, Reddy, N. Laxma, Hu, Lain Yen, Cotter, Ronald E, Hamilton, Philip N, Weber, Eckard, Keana, John F. W
Format Journal Article
LanguageEnglish
Published Washington, DC American Chemical Society 09.07.1993
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:IDDC (3, 10,5-(iminomethano)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene++ +) and a series of substituted derivatives were synthesized and evaluated in vitro for their ability to displace tritiated MK-801 ([3H]-2) from its specific binding site in guinea pig brain homogenate. Substitution at the 3-position of 3 with bromine, chlorine, and fluorine led to increased binding affinity. In contrast, substitution of donor groups at the 3-position gave decreased binding affinities, as did all substitutions at the 7-position and on nitrogen. Where racemic mixtures were resolved, the (+)-optical antipodes were more active than their enantiomers or racemates. The most active ligand found in this study was (+)-13e (IC50 = 15.5 +/- 4.5 nM). The affinity of (+)-13e for the PCP receptor makes it among the most potent ligands known. In vitro neuroprotection was demonstrated by 3, (+)-3, and (+)-6 (N-Me-IDDC) against glutamate-induced cell death in rat hippocampal cells.
Bibliography:istex:57EAE0566C58DB413686C466E6C20B834BA62749
ark:/67375/TPS-HFQM02Z7-P
ISSN:0022-2623
1520-4804
DOI:10.1021/jm00066a002